CUMBERLAND PHARMACEUTICALS
52 WEEK RANGE1.4695USD-9.07USD
| Date | Time | Price |
|---|
9/17/2026 | 4:15:00 PM | 7.24 |
Last news
In an interview with Bloomberg Línea, Federico Sturzenegger outlined plans for sweeping state reforms before delegated powers expire in July. He also explained why he believes these changes will outlast the current administration
Co-founder and CEO, Marcelo Abritta, explained the strategy behind the startup’s more than US$100M in revenue and plans to grow by 50% in 2025
Finance Minister Diego Guevara told Bloomberg Linea the central bank’s new co-directors are technically qualified, while bringing a broader vision to monetary policy compared to their predecessors
Discovery Capital Management founder Rob Citrone told Bloomberg Línea that capital flows to the country should surge once capital controls end. The hedge fund led returns among peers last year
